期刊文献+

重组痘病毒表达裂谷热病毒囊膜蛋白及其免疫原性分析 被引量:3

Recombinant vaccinia viruses expressing envelope glycoproteins of rift valley fever virus
下载PDF
导出
摘要 裂谷热(Rift valley fever,RVF)是由裂谷热病毒(Rift valley fever virus,RVFV)引起的烈性人畜共患传染病。囊膜糖蛋白G是病毒的主要结构蛋白,由基因组M节段编码,翻译后裂解为Gn和Gc,其中Gn为诱导中和抗体的主要免疫原。本研究分别构建了表达RVFV囊膜蛋白G(n+c)和Gn的重组痘病毒rVV-G (n+c)和rVV-Gn。SDS-PAGE、Western blot结果表明分子量分别为56 Ku(Gn)、58 Ku(Gc)左右的重组蛋白在rVV-G(n+c)和rVV-Gn哺乳动物细胞获得准确表达[G(n+c)裂解为Gn和Gc],并具有特异免疫反应原性。以rBac-G(n+c)和rBac-Gn感染的昆虫细胞裂解物为包被抗原,间接ELISA检测血清抗体结果显示,rVV-G (n+c)和rVV-Gn免疫小鼠可诱导显著的Gn、Gc特异抗体反应,并且rVV-G(n+c)免疫诱导主要保护性免疫原Gn特异抗体反应效果优于rVV-Gn。结果表明,表达全长囊膜糖蛋白重组痘病毒rG(n+c)具有作为安全有效的重组病毒活载体疫苗的潜力,为RVF重组亚单位疫苗的探索研究奠定了基础。 The glycoprotein G (n+c) of rift valley fever virus is encoded by M segment of the virus genome and subsequently cleaved into two envelope proteins, Gn and Gc. The Gn has been confirmed as most important immunogen to induce protective neutralization antibody. In this study, two recombinant vaccinia viruses, rVV-G (n+c) and rVV-Gn, were constructed. The expression of Gn and Gc (56 Ku and 58 Ku respectively) in rVV-G (n+c) or rVV-Gn infected cells was confirmed by SDS-PAGE and Western blot. C,n specific antibodies in mice immunized with rVV-G (n+c) or rVV-Gn were detected by indirect ELISA using recombinant G (n+c) or Gn as coating antigens, rVV-G (n+c) elicited more significant Gn specific antibody response than rVV-Gn. The results indicated that recombinant vaccinia viruses could be used as safe and effective vaccine for the prevention and control of rift valley fever.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2007年第6期409-413,共5页 Chinese Journal of Preventive Veterinary Medicine
基金 国家"攻关"项目(2004BA519A19 2005BA711A10) "973"项目(2005CB523200)资助
关键词 裂谷热病毒 囊膜蛋白 重组痘病毒 ELISA rift valley fever virus glycoprotein recombinant vaccinia virus ELISA
  • 相关文献

参考文献8

  • 1Daubney R,J R Hudson,P C Gamham.Enzootic hepatitis or Rift Valley fever:an undescribed virus disease of sheep,cattle and man from East Africa[J].Journal of Pathology and Bacteriology,1931,34:545-579.
  • 2Woods C W,Karpati A M,Grein T,et al.An Outbreak of Rift Valley Fever in Northeastern Kenya,1997-1998[J].Emerging Infectious Diseases,2002,8(2):138-144.
  • 3L T Kakach,T L Wasmoen,M S Collett.Rift Valley fever virus M segment:use of recombinant vaccinia viruses to study Phlebovirus gene expression[J].J Virol,1988,62(3):826-833.
  • 4Rice R M,Erlick B J,Rosato R R,et al.Biochemical characterisation of Rift Valley fever virus[J].Virology,1980,105:256-260.
  • 5Collett M S,Purchio A F,Keegan K,et al.Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus[J].Virologys,1985,15,144(1):228-245.
  • 6Bisht H,Roberts A,Vogel L,et al.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice[J].Proc Natl Acad Sci,2004,27:6641-6646.
  • 7Moss B.Genetically engineered poxviruses for recombinant gene expression,vaccination,and safety[J].Proc Natl Acad Sci,1996,21:11341-11348.
  • 8Fogg C,Lustig S,Whitbeck J C,et al.Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions[J].J Virol,2004,78:10230-10237.

同被引文献23

  • 1赫兢,郑少兰.人畜共患的蚊传裂谷热[J].传染病信息,2004,17(2):72-73. 被引量:1
  • 2鄢志强,李贺,吕平,刘计亮,马保华.裂谷热诊断技术研究进展[J].动物医学进展,2007,28(6):93-95. 被引量:6
  • 3王清华,王喜军,胡森,葛金英,步志高,林祥梅.裂谷热病毒囊膜蛋白基因DNA免疫的研究[J].微生物学报,2007,47(4):677-681. 被引量:4
  • 4Balkhy H H,Memish Z A.Rift Valley fever:an uninvited zoonosis in the Arabian peninsula.Int[J].Antimicrob,2003.21:153-157.
  • 5Bird B H,Nichol S T.Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide amodel of human delayed onset neurologic disease[J].Virology,2007,362:10-15.
  • 6Bouloy M,Flick R.Reverse genetics technology for Rift Valley fever virus:current and future applications for the development of therapeutics and vaccines[J].Antiviral Res,2009,84:101-118.
  • 7Saluzzo J F,Smith J F.Use of reassortant viruses to map attenuating and tempe-rature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine[J].Vaccine,1990,8(4):369-375.
  • 8Lorenzo G,Martín-Folgar R,Rodriguez F,et al.Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep[J].Vaccine,2008,26:5255-5262.
  • 9Liu L,Roy P.Rift Valley fever virus structural proteins:expression,characterization and assembly of recombinant proteins[J].Virology,2008,5:82.
  • 10Lagerqvist N,Lundkvist A,Bouloy M,et al.Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley fever virus cDNA constructs[J].Virology,2009,6:6.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部